The Texas Heart Institute Journal: Volume 50, Issue 6

The Texas Heart Institute Journal is an online peer-reviewed, international journal covering the broad field of cardiovascular diseases. The Journal aims to be a highly reputable and well-balanced reference that highlights practical techniques and pathways of care and delivers high-impact scientific contributions from clinicians in all disciplines of cardiovascular medicine. Subjects include coronary, peripheral, structural, and congenital heart disease, and cardiovascular anesthesia. The Journal publishes original research contributions, editorials, reviews, meta-analyses, case reports, images, and letters to the editor.

In 2023, we introduced important updates to The Journal with Volume 50, Issue 1. The most striking changes include a modified logo and a switch to blue accents. More importantly, article formats are structured to deliver messages more concisely (see New Author Instructions for details).

Please consider submitting your research results and other scientific contributions to The Journal. Authorship is open to all clinicians and research scientists with an interest in prevention, diagnosis, and treatment of cardiovascular disease. Moreover, our continuous publication schedule enables articles to be published within six to eight weeks of acceptance.

We also encourage you to read The Journal to keep up to date on what is happening in the field of cardiovascular medicine.

Zvonimir Krajcer, MD
Editor-in-Chief

Volume 50, Issue 6 of The Texas Heart Institute Journal Online

WOMEN’S HEART & VASCULAR SYMPOSIUM

The 2022 American College of Cardiology Expert Consensus on the Role of Nonstatin Therapies: An Expert-Guided Tour
Mini G. Varughese, MD; Christie M. Ballantyne, MD

CORRESPONDENCE

Remembering Paolo Angelini, MD
Roberto Lufschanowski, MD; Eduardo Hernandez-Vila, MD

Paolo Angelini’s Legacy in the Study of and Treatment for Anomalous Coronary Arteries
Pitt O. Lim, MD

CLINICAL INVESTIGATION

Characterization of Myocardial Injury With High-Sensitivity Troponin
Sant Kumar, MD; Nayrana Griffith, MD, MBA; Dylan Walter, MD; Michael Swett, MD; Venkatesh Raman, MD; Jose D. Vargas, MD, PhD; Brototo Deb, MD; Jiling Chou, BS; Ayah Arafat, BS; Monvadi B. Srichai, MD, MS

Cardioprotective Effects of Sodium-Glucose Cotransporter 2 Inhibitors and Their Possible Association With Normalization of the Circadian Index of Heart Rhythm
Nazile Bilgin Dogan, MD; Hamiyet Yilmaz Yasar, MD; Baris Kilicaslan, MD

ALI MASSUMI CARDIAC ARRHYTHMIA SYMPOSIUM

Subcutaneous vs Transvenous Implantable Cardioverter-Defibrillators: A Brief Review of the Current Landscape
Henry C. Zheng, MD; Hamid Afshar, MD

Established and Emerging Device Therapy in Heart Failure: Cardiac Contractility Modulation
Justin Haloot, DO, MS; Mihail G. Chelu, MD, PhD

CASE REPORTS

Idiopathic Dilatation of the Right Atrium: Diagnosis and Management
Ljiljana Rankovic-Nicic, MD; Milica Dragicevic-Antonic, MD; Goran Loncar, MD, PhD; Masa Petrovic, BS, MS; Zelimir Antonic, MD; Milovan Bojic, MD, PhD

A Transesophageal Cardiovascular Intervention
Alexander Loch, MD; Victoria Wen Yeng Teoh; Ida Normiha Hilmi, MD, PhD

Delayed Giant Pseudoaneurysm With Left-to-Right Shunt Following Postinfarct Ventricular Septal Perforation Repair
Yojiro Machii, MD; Makoto Taoka, MD, PhD; Yuki Hayashi, MD, PhD; Atsushi Harada, MD, PhD; Keita Kamata, MD; Masashi Tanaka, MD, PhD

IMAGES IN CARDIOVASCULAR MEDICINE

Left Main Coronary Artery and Bilateral Mammary Artery Aneurysms in a Patient With Extensive Aortopathy
Ala’ Arafah, MD; Richard Pham, MD; Steven J. Filby, MD

AUTHOR INSTRUCTIONS

The Texas Heart Institute Journal publishes articles on all aspects of preventing, diagnosing, and treating cardiovascular disease from a clinical perspective. The editors welcome original research and educational articles, as well as opinion pieces and essays related to medical discipline.